Enrolling by invitationNot applicableNCT06945640
Evaluation of 'RUS NE' in Robot-Assisted Partial Nephrectomy: Efficacy, Safety, and Stability
Studying Hereditary clear cell renal cell carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hutom Corp
- Intervention
- RUS NE(device)
- Enrollment
- 80 enrolled
- Eligibility
- 20-80 years · All sexes
- Timeline
- 2025 – 2026
Study locations (1)
- Asan Medical Center, Seoul, South Korea
Collaborators
Asan Medical Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06945640 on ClinicalTrials.govOther trials for Hereditary clear cell renal cell carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07293351A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)Bristol-Myers Squibb
- RECRUITINGPHASE1NCT07401875A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)M.D. Anderson Cancer Center
- RECRUITINGPHASE2NCT07489534Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal DysfunctionDaihong Liu
- RECRUITINGPHASE2NCT07229040A Double-blind Non Inferiority Clinical Trial to Compare the Nephroprotection of Cilastatn Versus Thiosulfate in Patients Undergoing Debulking Surgery With Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Cisplatin.Hospital General Universitario Gregorio Marañon
- RECRUITINGNANCT07367750Testing the Feasibility of a Self-Management Support Program for Patient With Chronic Diseases in IsraelUniversity of Haifa
- RECRUITINGNCT07303725Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional OncologyPalo Alto Veterans Institute for Research
- RECRUITINGPHASE1NCT06623630Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal FunctionWashington University School of Medicine
- RECRUITINGNCT06600646Investigating the Role of ATP Production by Airway Epithelium in Patients With Refractory and Unexplained Chronic Cough (RCC/UCC).McMaster University
See all trials for Hereditary clear cell renal cell carcinoma →